NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis
Advanced SearchBrowse by AnalyteBrowse by Pre-analytical FactorSearch SOPsSOP Compendiums

Factor Assay – VIII, IX, XI, XII   Add to my SOP compendium

BRD ID: 2,022

Source: TCP Project Tier: SOP Number of times downloaded: 1117

Description

This document describes the protocol used by the Pathology and Laboratory Medicine Department of Boston Medical Center (BMC) to measure clotting factor activity in plasma as part of the Thrombosis in Cancer Patients (TCP) Project. It is a product of the Center for Strategic Scientific Initiatives (CSSI) of the National Institutes of Health (NIH) (https://www.cancer.gov/about-nci/organization/cssi/research/past-programs#thrombosis-in-cancer-standardization-of-biomarker-measurements).

Documents for Download

BARC PRO 013 Factor VIII activity.pdf [Size: 2707 KB]
Biospecimens
  • Fluid - Plasma
Diagnoses
  • Normal
  • Neoplastic - Carcinoma
Topics
  • Biospecimen Processing
  • Platform-specific Methodology

Associated SOP Compendiums

News and Announcements

  • 2025’s Most Popular SOPs: See What Users Downloaded Most
  • Improving RNAseq Analysis of Small Biospecimens: New Recommendations Available
  • 2026 NCI Best Practices for Biospecimen Resources is Now Available!
    • More...